Crossmark

Societal costs and survival of patients with biopsy-verified non-alcoholic steatohepatitis: Danish nationwide register-based study

Crossref DOI link: https://doi.org/10.1016/j.aohep.2024.101285

Published Print: 2024-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rudolfsen, Jan Håkon http://orcid.org/0000-0002-4058-056X
Gluud, Lise Lotte http://orcid.org/0000-0002-9462-4468
Grønbæk, Henning

Jensen, Majken K.

Vyberg, Mogens

Olsen, Jens

Bo Poulsen, Peter http://orcid.org/0000-0002-5279-4637
Hovelsø, Nanna

Gregersen, Nikolaj Ture

Thomsen, Anne Bloch

Jepsen, Peter
Funding

Funding for this research was provided by:

Pfizer
License Information

Text and Data Mining valid from 2024-05-01

Text and Data Mining valid from 2024-05-01

Version of Record valid from 2024-01-18
More Information

This article is maintained by: Elsevier

Article Title: Societal costs and survival of patients with biopsy-verified non-alcoholic steatohepatitis: Danish nationwide register-based study

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2024.101285

Content Type: article

Copyright: © 2024 Published by Elsevier España, S.L.U. on behalf of Fundación Clínica Médica Sur, A.C.